Suppr超能文献

与神经退行性疾病相关的 UCHL1 突变体中蛋白动力学改变和催化半胱氨酸更具反应性。

Altered Protein Dynamics and a More Reactive Catalytic Cysteine in a Neurodegeneration-associated UCHL1 Mutant.

机构信息

Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, IN 47907, United States.

Institute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.

出版信息

J Mol Biol. 2024 Feb 15;436(4):168438. doi: 10.1016/j.jmb.2024.168438. Epub 2024 Jan 5.

Abstract

A mutant of ubiquitin C-terminal hydrolase L1 (UCHL1) detected in early-onset neurodegenerative patients, UCHL1, showed higher catalytic activity than wild-type UCHL1 (UCHL1). Lying within the active-site pocket, the arginine is part of an interaction network that holds the catalytic histidine in an inactive arrangement. However, the structural basis and mechanism of enzymatic activation upon glutamine substitution was not understood. We combined X-ray crystallography, protein nuclear magnetic resonance (NMR) analysis, enzyme kinetics, covalent inhibition analysis, and biophysical measurements to delineate activating factors in the mutant. While the crystal structure of UCHL1 showed nearly the same arrangement of the catalytic residues and active-site pocket, the mutation caused extensive alteration in the chemical environment and dynamics of more than 30 residues, some as far as 15 Å away from the site of mutation. Significant broadening of backbone amide resonances in the HSQC spectra indicates considerable backbone dynamics changes in several residues, in agreement with solution small-angle X-ray scattering (SAXS) analyses which indicate an overall increase in protein flexibility. Enzyme kinetics show the activation is due to a k effect despite a slightly weakened substrate affinity. In line with this, the mutant shows a higher second-order rate constant (k/K) in a reaction with a substrate-derived irreversible inhibitor, Ub-VME, compared to the wild-type enzyme, an observation indicative of a more reactive catalytic cysteine in the mutant. Together, the observations underscore structural plasticity as a factor contributing to enzyme kinetic behavior which can be modulated through mutational effects.

摘要

在早发性神经退行性疾病患者中检测到泛素 C 端水解酶 L1 (UCHL1) 的突变体,UCHL1 比野生型 UCHL1 (UCHL1) 具有更高的催化活性。位于活性位点口袋内的精氨酸是相互作用网络的一部分,该网络将催化组氨酸保持在非活性排列。然而,对于谷氨酰胺取代时酶的激活的结构基础和机制尚不清楚。我们结合 X 射线晶体学、蛋白质核磁共振(NMR)分析、酶动力学、共价抑制分析和生物物理测量来描绘突变体中的激活因素。虽然 UCHL1 的晶体结构显示催化残基和活性位点口袋的排列几乎相同,但该突变导致超过 30 个残基的化学环境和动力学发生广泛改变,有些残基距离突变部位甚至达到 15Å。HSQC 光谱中酰胺共振的显著展宽表明几个残基的骨架动力学发生了相当大的变化,这与溶液小角 X 射线散射(SAXS)分析一致,表明蛋白质整体柔韧性增加。酶动力学显示,尽管底物亲和力略有减弱,但激活是由于 k 效应。与此一致的是,与野生型酶相比,突变体与底物衍生的不可逆抑制剂 Ub-VME 的反应中表现出更高的二级速率常数(k/K),这一观察结果表明突变体中具有更具反应性的催化半胱氨酸。总之,这些观察结果强调了结构可塑性是影响酶动力学行为的因素之一,可以通过突变效应进行调节。

相似文献

1
Altered Protein Dynamics and a More Reactive Catalytic Cysteine in a Neurodegeneration-associated UCHL1 Mutant.
J Mol Biol. 2024 Feb 15;436(4):168438. doi: 10.1016/j.jmb.2024.168438. Epub 2024 Jan 5.
3
Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation.
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9117-22. doi: 10.1073/pnas.0910870107. Epub 2010 May 3.
5
The co-crystal structure of ubiquitin carboxy-terminal hydrolase L1 (UCHL1) with a tripeptide fluoromethyl ketone (Z-VAE(OMe)-FMK).
Bioorg Med Chem Lett. 2012 Jun 15;22(12):3900-4. doi: 10.1016/j.bmcl.2012.04.124. Epub 2012 May 4.
6
Mechanism of the Rpn13-induced activation of Uch37.
Protein Cell. 2014;5(8):616-30. doi: 10.1007/s13238-014-0046-z. Epub 2014 Apr 22.

本文引用的文献

1
UCSF ChimeraX: Tools for structure building and analysis.
Protein Sci. 2023 Nov;32(11):e4792. doi: 10.1002/pro.4792.
3
Ubiquitin C‑terminal hydrolase‑L1: A new cancer marker and therapeutic target with dual effects (Review).
Oncol Lett. 2023 Feb 8;25(3):123. doi: 10.3892/ol.2023.13709. eCollection 2023 Mar.
4
Characterization of Deubiquitinase Catalytic State Using a Structure-Based Approach.
Methods Mol Biol. 2023;2591:1-15. doi: 10.1007/978-1-0716-2803-4_1.
5
Structural basis for specific inhibition of the deubiquitinase UCHL1.
Nat Commun. 2022 Oct 10;13(1):5950. doi: 10.1038/s41467-022-33559-4.
7
UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma.
World J Surg Oncol. 2022 May 11;20(1):153. doi: 10.1186/s12957-022-02620-3.
8
Performance of the new biological small- and wide-angle X-ray scattering beamline 13A at the Taiwan Photon Source.
J Appl Crystallogr. 2022 Mar 18;55(Pt 2):340-352. doi: 10.1107/S1600576722001923. eCollection 2022 Apr 1.
9
Impacts of Cancer-associated Mutations on the Structure-Activity Relationship of BAP1.
J Mol Biol. 2022 May 15;434(9):167553. doi: 10.1016/j.jmb.2022.167553. Epub 2022 Mar 19.
10
Oxidation of catalytic cysteine of human deubiquitinase BAP1 triggers misfolding and aggregation in addition to functional loss.
Biochem Biophys Res Commun. 2022 Apr 9;599:57-62. doi: 10.1016/j.bbrc.2022.02.029. Epub 2022 Feb 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验